Portfolio manager highlights AbbVie, Pfizer and Medtronic as compelling large-cap health care dividend plays with growth and ...
Migraines. Those who do not have them will never truly understand them. The pain. The fog. The effects they can cause, the way they steal hours, sometimes days, from a life. For Gabrielle Mazzaro, ...
TipRanks on MSN
Lenz drops nearly 30% after FDA’s FAERS finds retinal tear
Shares of Lenz Therapeutics (LENZ) dropped after a case of retinal tear surfaced inn the FDA’s adverse-event database known as FAERS. The company, ...
Two leading medical stocks that appear reasonable at current levels are AbbVie (NYSE: ABBV) and Merck (NYSE: MRK). The former ...
Dividend investing rewards patience. The best dividend stocks don’t just pay consistently—they raise payouts year after year, ...
AbbVie dips below its 50-day SMA, but strong immunology momentum and a resilient long-term trend keep the story compelling.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback